Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Depreciation & Amortization (IS) (2024 - 2025)

Historic Depreciation & Amortization (IS) for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Q3 2025 value amounting to $14.1 million.

  • Amphastar Pharmaceuticals' Depreciation & Amortization (IS) rose 544.03% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.8 million, marking a year-over-year change of. This contributed to the annual value of $53.0 million for FY2024, which is 3925.86% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Depreciation & Amortization (IS) stood at $14.1 million for Q3 2025, which was up 544.03% from $14.6 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Depreciation & Amortization (IS)'s 5-year high stood at $14.6 million during Q2 2025, with a 5-year trough of $13.0 million in Q1 2024.